A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia
Clinical trial NCT03382639 · COMPLETED
Trial details
- NCT number
- NCT03382639
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-04
- Primary completion
- 2020-12-29
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.